Arthneeti
Jyoti ResinsQ4 FY24

Jyoti Resins Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹867.85P/E: 16.2Market Cap: ₹1.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

No

Order

N/A

Capex

Yes

1 of 4 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2
  • Industry growth projected at 5%-7%, with Jyoti Resins expecting to outperform due to focus on developing states (West Bengal, Telangana, Delhi, UP).
  • Gradual, district-by-district market penetration targeting stable regions with repeat customers to ensure streamlined payments.
  • Existing capacity utilized at 55%; no immediate CapEx planned for FY24, but expansions expected from next year as needed.
  • Parallel growth in mature states via market share gains (~Gujarat from 35% to 40%), but higher volume growth anticipated from newer states with lower base penetration.
  • Compound annual growth rate guidance of 20%-25% over 3-5 years, emphasizing steady sustainable growth rather than quarter-to-quarter spikes.
  • Volume growth supported by increased dealer network, CRM investments, and loyalty programs, targeting both urban and rural markets with infrastructure development.
  • Focus on retaining existing customers before aggressive expansion, with a long-term horizon for growth clarity.

See what Jyoti Resins management said on margin guidance — free account, 30 seconds.

Fundraise plans

No
- Current capacity utilization is at 55%, and the company is serving existing and new markets using existing capacity. - There is no immediate requirement for capital expenditure (CapEx) for the current financial year as per management statements. - Plans to start new CapEx will commence from the end of the current financial year and will be executed during the next year. - No mention of any current or near-future fundraising through debt or equity was made. - The company is currently debt-free and managing growth using internal funds and cash reserves (~₹120 crores). - Future expansion and growth plans will likely be funded internally without immediate external fundraising. Overall, no explicit plans for new fundraising through debt or equity have been disclosed in the call transcript.

See what Jyoti Resins management said on order book — free account, 30 seconds.

Capex plans

Yes
  • New CapEx planning will start from next year, to be executed fully within two years (Page 23).
  • Current capacity utilization is around 55%, serving existing markets without immediate CapEx (Page 28).
  • Planned CapEx of ₹30-35 crores focused on capacity expansion, product awareness, branding, marketing, and team building (Page 22).
  • Company has already applied for environmental clearance to expand capacity from 2,000 tons to 5,000 tons at one site (Page 19).
  • No CapEx requirement in the current financial year; expansion plans will commence from year-end and execute next year (Page 24).
  • Strategic investments are focused on expanding dealer network, strengthening CRM and ERP systems, and geographical penetration, especially in new states (Pages 8, 19, 28).

Track Jyoti Resins — get its next earnings analysis in your feed

Margin guidance

Category 3
  • The company targets a compounded annual growth rate (CAGR) of 20% to 25% in revenue over the next 3-5 years, based on the revised base of FY24.
  • EBITDA margins are expected to normalize in the range of 22% to 25%, considered a sustainable and good margin for growth.
  • Management plans to sacrifice some margin (from current 32-34% EBITDA) to invest in branding, marketing, and loyalty programs to drive volume growth.
  • Capacity utilization is currently at 55%, with plans to increase utilization, targeting ₹450-500 crores revenue at 90% utilization.
  • CapEx of ₹30-35 crores is planned mainly for next year to support capacity expansion and market penetration.
  • Growth focus is on developing states (West Bengal, Telangana, Delhi, UP) expected to drive faster volume growth than mature markets.
  • The strategy emphasizes long-term growth with a 3-5 year horizon rather than quarter-to-quarter performances.

Order book

The transcript does not explicitly mention the current or expected order book or pending orders in detail. However, relevant insights regarding business and market expansion include: - Business model focuses on gradual, district-by-district market penetration to build repeat customers and ensure payment stability (Page 28). - Capacity utilization is currently at about 55%, with existing capacity sufficient to serve current demand; plans to expand CapEx and capacity are underway as needed (Pages 22, 23, 28). - Management emphasizes that business growth is long-term (3-5 years horizon), focusing on steady expansion rather than short-term volume spikes (Pages 21, 28). - Sales seen in strong geographies like Delhi, UP, and expansion planned into new states after establishing stability (Page 28). - CapEx planning and execution for new capacity to begin next year and complete within two years (Page 23). No exact figures for pending orders or order book are disclosed.

How does Jyoti Resins rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisJyoti Resins
Rev 2Mar 3
See where Jyoti Resins sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Jyoti Resins rank in Chemicals & Petrochemicals?

Compare Jyoti Resins against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Continue your research

What Jyoti Resins's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Sudarshan Chemical Industries Ltd (Q1 FY27)

    The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…

  • Indo Borax & Ch. (Q1 FY27)

    250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…

  • SRF (Q1 FY27)

    Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…

  • Deepak Fertilis. (Q1 FY27)

    Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…

Compare:vs Solar Industries India Ltdvs Pidilite Inds.vs SRF

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →